DNAJC2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.754200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.772600E-01
Normal-vs-Stage2
4.672800E-01
Normal-vs-Stage3
7.076200E-01
Normal-vs-Stage4
1.347810E-01
Stage1-vs-Stage2
6.401600E-01
Stage1-vs-Stage3
3.607200E-01
Stage1-vs-Stage4
8.132000E-02
Stage2-vs-Stage3
2.295800E-01
Stage2-vs-Stage4
4.033700E-02
Stage3-vs-Stage4
7.624000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.361800E-01
Normal-vs-AfricanAmerican
6.056400E-01
Normal-vs-Asian
6.276000E-01
Caucasian-vs-AfricanAmerican
9.085800E-01
Caucasian-vs-Asian
8.031600E-01
AfricanAmerican-vs-Asian
8.249400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.412800E-01
Normal-vs-Female
6.347800E-01
Male-vs-Female
1.847000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.938600E-01
Normal-vs-Age(41-60Yrs)
3.119800E-01
Normal-vs-Age(61-80Yrs)
6.144400E-01
Normal-vs-Age(81-100Yrs)
3.264600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.287800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.560000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.220800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.338400E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.597200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.213200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.193000E-01
Normal-vs-Daily Drinker
5.090200E-01
Normal-vs-Weekly Drinker
3.385800E-01
Normal-vs-Occasional Drinker
4.190400E-01
Normal-vs-Social Drinker
1.482420E-01
Non Drinker-vs-Daily Drinker
6.738200E-01
Non Drinker-vs-Weekly Drinker
4.961200E-01
Non Drinker-vs-Occasional Drinker
6.310600E-01
Non Drinker-vs-Social Drinker
5.366200E-01
Daily Drinker-vs-Weekly Drinker
2.471000E-01
Daily Drinker-vs-Occasional Drinker
9.507800E-01
Daily Drinker-vs-Social Drinker
1.754450E-01
Weekly Drinker-vs-Occasional Drinker
2.229000E-01
Weekly Drinker-vs-Social Drinker
7.750800E-01
Occasional Drinker-vs-Social Drinker
1.223400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.083200E-01
Normal-vs-Grade 2
3.697400E-01
Normal-vs-Grade 3
3.554000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.784050E-02
Grade 1-vs-Grade 3
1.813980E-02
Grade 1-vs-Grade 4
8.083200E-01
Grade 2-vs-Grade 3
7.346800E-01
Grade 2-vs-Grade 4
3.697400E-01
Grade 3-vs-Grade 4
3.554000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.603600E-01
Normal-vs-NonDiabetic
4.721800E-01
Diabetic-vs-NonDiabetic
5.841000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.431600E-01
Normal-vs-NoPancreatitis
5.055400E-01
Pancreatitis-vs-NoPancreatitis
3.691400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.295800E-01
Normal-vs-N1
4.824200E-01
N0-vs-N1
3.227000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.953820E-01
Normal-vs-TP53-NonMutant
5.524000E-01
TP53-Mutant-vs-TP53-NonMutant
1.254400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
